摘要
目前手术切除仍是根治肝门部胆管癌的唯一方法,但是手术切除率及切净率均较低。局部复发是导致治疗失败及病死的:最主要因素。近10余年来,随着肝门部胆管癌术前、术中、术后放疗应用的增多,多数文献显示放疗作为手术辅助性治疗手段,对改善患者生存期及生存质量是有益的。
The primary curative modality for hilar cholangiocarcinoma is surgery. Some reports suggest that radical resection may provide the best survival rate for patients with hilar cholangiocarcinoma. In resected patients, however, gross or microscopic residual disease is common. Local recurrence is the most common cause of failure and mortality. In the past 10 years, preoperative, intraoperative and postoperative radiotherapy has been used as an adjuvant treatment for these patients. Some studies have proved adjuvant radiotherapy on hilar cholangiocarcinoma may be of value.
出处
《中国癌症杂志》
CAS
CSCD
2004年第2期197-200,共4页
China Oncology
关键词
肝门部胆管癌
放射治疗
手术
hilar cholangiocarcinorna
radiotherapy
surgery
